Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)

Summary

This phase II trial is studying how well bortezomib works in treating patients with hepatocellular carcinoma (liver cancer) that cannot be removed with surgery. Bortezomib may stop the growth of tumor cells by blocking the enzymes necessary for their growth.

Timeline

Start

2005-04

Primary completion

2006-06

Completion

—

Drugs

Indications